Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy
Hassan A Aziz,1 Charlotte E LaSenna,2 Michael Vigoda,1,2 Cristina Fernandes,2 William Feuer,1 Mohammed Ali Aziz-Sultan,2 Timothy G Murray1–31Bascom Palmer Eye Institute, Miami, FL, USA; 2University of Miami, Miami, FL, USA; 3Murray Ocular Oncology & Retina, Miami, FL, USAPu...
Guardado en:
Autores principales: | Aziz HA, LaSenna CE, Vigoda M, Fernandes C, Feuer W, Aziz-Sultan MA, Murray TG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5ff384f22294c39a4b5774f5fca0289 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma
por: Lejla Mutapcic Vajzovic, et al.
Publicado: (2011) -
Prevalence of refractive errors in children with retinoblastoma
por: Villegas VM, et al.
Publicado: (2019) -
Retinoblastoma
por: Marchevsky,Silvia, et al.
Publicado: (1979) -
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah NV, et al.
Publicado: (2012) -
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden
por: Tao Qing, et al.
Publicado: (2020)